logo
Select company
Select metric
5.26Current Ratio
VS
Market
84
Sector
67
Industry
54
History
5
$ 70.82Close
$ 36.45 - $ 74.97 52-Week Range
Ticker Information

Ticker

TARS

Company Name

TARSUS PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TARSUS PHARMACEUTICALS INC - Current Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TARS - Current Ratio Historical data
DateCurrent AssetsCurrent RatioCurrent Liabilities
6/30/2025$ 474.43M5.26$ 90.25M
3/31/2025$ 480.77M5.57$ 86.31M
12/31/2024$ 356.7M4.42$ 80.61M
9/30/2024$ 357.12M5.42$ 65.87M
6/30/2024$ 362.59M7.03$ 51.57M
3/31/2024$ 340.72M8.01$ 42.53M
12/31/2023$ 256.13M6.93$ 36.94M
9/30/2023$ 259.28M11.15$ 23.25M
6/30/2023$ 183.48M12.43$ 14.77M
3/31/2023$ 208.65M15.74$ 13.26M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TARSUS PHARMACEUTICALS INC's latest trailing twelve months (TTM) Current Ratio stands at 14.5.
  • Over the past 5 years, TARSUS PHARMACEUTICALS INC's average Current Ratio has been 13.31.
  • The median Current Ratio for TARSUS PHARMACEUTICALS INC during this period was 14.34
  • TARSUS PHARMACEUTICALS INC reached its highest Current Ratio over the past 5 years at 31.68.
  • The lowest Current Ratio recorded by TARSUS PHARMACEUTICALS INC in the same timeframe 4.42

TARSUS PHARMACEUTICALS INC's Current Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Current Ratio Benchmarks
CompanyCurrent Ratio
ARQT : ARCUTIS BIOTHERAPEUTICS INC 3.2VCEL : VERICEL CORP 4.97TVTX : TRAVERE THERAPEUTICS INC 2IMCR : IMMUNOCORE HOLDINGS PLC 5.89ADPT : ADAPTIVE BIOTECHNOLOGIES CORP 2.84MNKD : MANNKIND CORP 2.5AUPH : AURINIA PHARMACEUTICALS INC 5.23RCUS : ARCUS BIOSCIENCES INC 4.5XERS : XERIS BIOPHARMA HOLDINGS INC 1.95INVA : INNOVIVA INC 2.64

Definition of Current Ratio

[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for TARSUS PHARMACEUTICALS INC is calculated as follows: AssetsC [ $ 89.07M ] / LiabilitesC [ $ 6.14M ]
(=) Current Ratio [ 14.5 ]

TARS - Current Ratio, Last 5 years

4.42

Minimum

Dec 31, 2024

31.68

Maximum

Dec 31, 2020

13.31

Average

14.34

Median

Current Ratio Benchmark Analysis

The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
filtered constituents3.2K
min0
max6.79
average2.02
median1.62
std1.44